Multiple Sclerosis News Today Forums › Forums › Trials and Research › MS Patients Switching From Tysabri May Risk Disease Activity, Study Says

  • Trials and Research

    MS Patients Switching From Tysabri May Risk Disease Activity, Study Says

    Posted by MS News Today Moderator on March 3, 2020 at 11:18 am

    Multiple sclerosis (MS) patients switching from Tysabri (natalizumab) to other disease-modifying therapies may have an increased risk of disease activity, though the risk is lower if the switch is limited to three months, a study found. Read more here.

    What do you think of this news?

    MS News Today Moderator replied 4 years, 1 month ago 0 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .